Dacetuzumab has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin Lymphoma, Leukemia, Lymphocytic, Chronic, and Lymphoma, Large B-Cell, Diffuse. It is a humanized anti-CD40 antibody and induces cytotoxicity in human multiple myeloma cells. 货号（Catalog No.） CSD00144 通用名INN Dacetuzumab 纯度(Purity) >95% 浓度( Concentration) 1mg/ml Formulation PBS buffer pH7.5 Source CHO cells 内毒素(Endotoxin level) Please contact with the lab for this information. 生物活性 产品描述(Description) Dacetuzumab has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin Lymphoma, Leukemia, Lymphocytic, Chronic, and Lymphoma, Large B-Cell, Diffuse. It is a humanized anti-CD40 antibody and induces cytotoxicity in human multiple myeloma cells. 别名(Alternative names) SGN-40,huS2C 靶点;物种(Specificity target name;species) CD40[Homo sapiens] 种类(Species) Humanized 受体鉴定(Receptor identification) IgG1-kappa 化学信息 CAS 880486-59-9 存储条件(Storage) store at -80°C
